How APLAID is Diagnosed

Achieving an accurate diagnosis for APLAID is often a journey of ruling out other conditions. Because its symptoms—such as early-onset skin rashes and recurrent fevers—overlap with other rare syndromes, many patients face delays in receiving the correct diagnosis ^[1][2].

The Challenge of Misdiagnosis

Because APLAID is so rare, doctors may first consider other important (though also rare) alternative diagnoses, such as:

• CAPS (Cryopyrin-Associated Periodic Syndromes): Causes similar fevers and rashes ^[1].
• DIRA (Deficiency of the IL-1 Receptor Antagonist): Often presents with pustular skin lesions in early infancy ^[1].
• FMF (Familial Mediterranean Fever): Characterized by recurrent fevers and joint pain ^[1][3].

APLAID is distinguished by its unique combination of autoinflammation and antibody deficiency (an inability to fight outside germs properly) ^[4].

Genetic Testing: A Key Diagnostic Step

Identifying a mutation in the PLCG2 gene is a critical step in diagnosing APLAID. This is typically done through Whole-Exome Sequencing (WES) or a targeted Inborn Errors of Immunity (IEI) panel, which looks at hundreds of genes known to affect the immune system ^[2][5].

However, simply finding a change in the PLCG2 gene does not automatically confirm APLAID. If the lab finds a Variant of Uncertain Significance (VUS)—a genetic change where the effect is not yet known—doctors must carefully match that finding with your clinical symptoms ^[6][7]. In some cases, specialized laboratories perform functional assays (such as measuring calcium flux in B cells) to prove the mutation alters protein function ^[4][8]. These tests are highly specialized and not universally available, so your specialist will determine if they are necessary to confirm your specific variant.

Evaluating the Immune System

Because APLAID involves an immune deficiency, a comprehensive “immune workup” is required. This helps your team understand how well the body can defend itself against infections ^[4].

1. Quantitative Immunoglobulins: This blood test measures the levels of different antibodies (IgG, IgA, and IgM). In APLAID, these levels are often low, though they can vary ^[4][6].
2. B-Cell Phenotyping: This is a detailed look at the types of B cells in the blood. Doctors specifically look at subsets like class-switched memory B cells (cells that “remember” previous infections or vaccines) ^[4][9].
3. Vaccine Response Testing: Your doctor may check your antibody “titer” levels after a vaccination (like the pneumonia shot) to see if your immune system was able to build an appropriate protective response ^[10][11].

Biopsies and Organ Screening

If skin symptoms are prominent, a skin biopsy may be performed. In APLAID, these biopsies often show dense inflammation without any signs of an actual infection (like bacteria or fungi) under the microscope ^[2][7]. While this pattern may support an inflammatory diagnosis, histology alone cannot perfectly rule out an infection, and cultures or molecular tests may still be needed if an infection is suspected.

Depending on your symptoms, screening of the eyes and gastrointestinal tract may also be recommended by experts to document the full reach of the condition at the time of diagnosis ^[1].